Qdenga is a dengue vaccine developed to help protect against dengue fever caused by multiple dengue virus serotypes. It supports immune system response and may reduce the risk of severe dengue-related complications in eligible individuals. Qdenga is administered under healthcare supervision according to approved vaccination schedules and medical recommendations. Vaccination programs play an important role in public health efforts to control dengue infections in endemic regions. Patients should consult healthcare professionals regarding suitability, dosage schedules, and preventive healthcare